Pharmacologic Interventions for Dementia Syndromes will explore intervention with an emphasis on using the published literature to choose pharmacological interventions for cognitive and behavioral manifestations of dementia, including the roles (i.e., indications and benefits), cautions (i.e., risks, side-effects, warnings) and potential alternatives to using cholinesterase inhibitors, memantine, antipsychotics, and antidepressants in ADRD. Finally, given the recent FDA approval of 3 amyloid imaging agents, this program will also help participants better understand how biomarkers are changing practices with regard to clinical research and management of ADRD.
Howard Aizenstein, MD, PhD, Professor of Psychiatry and Associate Professor of Bioengineering, and Clinical and Translational Science, University of Pittsburgh School of Medicine
Program is approved for CEs in PA
1.5 CEs each for Nursing, L/CSW, LPC, LMFT, Psychology
Registration price: $10 ( $35 full registration price, discounted $25 from HRSA grant -Geriatrics Workforce enhancement Program (GWEP)
Program supported by Health Resources and Services Administration Grant # U1QHP28736